Dipeptidyl peptidase-4 inhibitors and osteoporosis

被引：8
|
作者：
Lee, Wen-Ling [1 ,2 ,3 ]
Lee, Fa-Kung [4 ,5 ]
Wang, Peng-Hui [2 ,5 ,6 ,7 ]
机构：
[1] Cheng Hsin Gen Hosp, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan
[4] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[5] Female Canc Fdn, Taipei, Taiwan
[6] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, 201,Sect 2,Shi Pai Rd, Taipei 112, Taiwan
[7] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
来源：
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION | 2022年 / 85卷 / 09期
关键词：
RISK; NATIONWIDE; OUTCOMES; CARE;
D O I：
10.1097/JCMA.0000000000000775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：889 / 890
页数：2
相关论文
共 50 条
  • [1] The role of dipeptidyl peptidase-4 inhibitors
    Lasserson, Daniel
    Mant, Jonathan
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [2] Renal outcomes with dipeptidyl peptidase-4 inhibitors
    Scheen, A. J.
    Delanaye, P.
    DIABETES & METABOLISM, 2018, 44 (02) : 101 - 111
  • [3] Heart failure and dipeptidyl peptidase-4 inhibitors
    Krum, Henry
    Skiba, Marina
    Wu, Shiying
    Hopper, Ingrid
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 (06) : 603 - 607
  • [4] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Papagianni, M.
    Tziomalos, K.
    HIPPOKRATIA, 2015, 19 (03) : 195 - 199
  • [5] The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
    Kim, Na-Hyung
    Yu, Taeyang
    Lee, Dae Ho
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [6] Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
    Richard, Kathleen R.
    Shelburne, Jamie S.
    Kirk, Julienne K.
    CLINICAL THERAPEUTICS, 2011, 33 (11) : 1609 - 1629
  • [7] Dipeptidyl peptidase-4 inhibitors and cardiovascular safety
    Davis, Timothy M. E.
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (08) : 450 - 451
  • [8] Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
    Ametov, A. S.
    Kamynina, L. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (01) : 98 - 102
  • [9] The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
    Kanasaki, Keizo
    CLINICAL SCIENCE, 2018, 132 (04) : 489 - 507
  • [10] Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?
    Saisho, Y.
    Itoh, H.
    DIABETIC MEDICINE, 2013, 30 (04) : e149 - e150
12345